In vitro evaluation of CBR-2092, a novel rifamycin-quinolone hybrid antibiotic: microbiology profiling studies with staphylococci and streptococci.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples